221 related articles for article (PubMed ID: 17203107)
1. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors.
Bastone P; Romen F; Liu W; Wirtz R; Koch U; Josephson N; Langbein S; Löchelt M
Gene Ther; 2007 Apr; 14(7):613-20. PubMed ID: 17203107
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and characteristics of replication-competent revertants derived from self-inactivating foamy virus vectors.
Bastone P; Löchelt M
Gene Ther; 2004 Mar; 11(5):465-73. PubMed ID: 14973540
[TBL] [Abstract][Full Text] [Related]
3. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors.
Liu W; Backes P; Löchelt M
Virology; 2009 Nov; 394(2):208-17. PubMed ID: 19775717
[TBL] [Abstract][Full Text] [Related]
4. Comparative functional characterization of the feline foamy virus transactivator reveals its species specificity.
Bodem J; Kang Y; Flügel RM
Virology; 2004 Jan; 318(1):32-6. PubMed ID: 14972532
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs.
Mergia A; Chari S; Kolson DL; Goodenow MM; Ciccarone T
Virology; 2001 Feb; 280(2):243-52. PubMed ID: 11162838
[TBL] [Abstract][Full Text] [Related]
6. Gene transduction efficiency in cells of different species by HIV and EIAV vectors.
Ikeda Y; Collins MK; Radcliffe PA; Mitrophanous KA; Takeuchi Y
Gene Ther; 2002 Jul; 9(14):932-8. PubMed ID: 12085241
[TBL] [Abstract][Full Text] [Related]
7. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.
Zemba M; Alke A; Bodem J; Winkler IG; Flower RL; Pfrepper K; Delius H; Flügel RM; Löchelt M
Virology; 2000 Jan; 266(1):150-6. PubMed ID: 10612669
[TBL] [Abstract][Full Text] [Related]
8. Gene transfer using replication-defective human foamy virus vectors.
Bieniasz PD; Erlwein O; Aguzzi A; Rethwilm A; McClure MO
Virology; 1997 Aug; 235(1):65-72. PubMed ID: 9300037
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
10. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins.
Bastone P; Bravo IG; Löchelt M
Virology; 2006 Apr; 348(1):190-9. PubMed ID: 16443252
[TBL] [Abstract][Full Text] [Related]
11. Experimental therapy of allogeneic solid tumors induced in athymic mice with suicide gene-transducing replication-competent foamy virus vectors.
Heinkelein M; Hoffmann U; Lücke M; Imrich H; Müller JG; Meixensberger J; Westphahl M; Kretschmer A; Rethwilm A
Cancer Gene Ther; 2005 Dec; 12(12):947-53. PubMed ID: 15905857
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.
Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A
Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654
[TBL] [Abstract][Full Text] [Related]
13. The bet gene of feline foamy virus is required for virus replication.
Alke A; Schwantes A; Kido K; Flötenmeyer M; Flügel RM; Löchelt M
Virology; 2001 Sep; 287(2):310-20. PubMed ID: 11531409
[TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain.
Liehl B; Hlavaty J; Moldzio R; Tonar Z; Unger H; Salmons B; Günzburg WH; Renner M
Gene Ther; 2007 Sep; 14(18):1330-43. PubMed ID: 17611586
[TBL] [Abstract][Full Text] [Related]
15. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors.
Schambach A; Mueller D; Galla M; Verstegen MM; Wagemaker G; Loew R; Baum C; Bohne J
Gene Ther; 2006 Nov; 13(21):1524-33. PubMed ID: 16763662
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
17. Gene transfer in human skin with different pseudotyped HIV-based vectors.
Hachiya A; Sriwiriyanont P; Patel A; Saito N; Ohuchi A; Kitahara T; Takema Y; Tsuboi R; Boissy RE; Visscher MO; Wilson JM; Kobinger GP
Gene Ther; 2007 Apr; 14(8):648-56. PubMed ID: 17268532
[TBL] [Abstract][Full Text] [Related]
18. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
19. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.
Rothenaigner I; Kramer S; Meggendorfer M; Rethwilm A; Brack-Werner R
Gene Ther; 2009 Mar; 16(3):349-58. PubMed ID: 19052634
[TBL] [Abstract][Full Text] [Related]
20. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
